These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

766 related items for PubMed ID: 8214760

  • 1. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane.
    Kharasch ED, Thummel KE.
    Anesthesiology; 1993 Oct; 79(4):795-807. PubMed ID: 8214760
    [Abstract] [Full Text] [Related]

  • 2. Human kidney methoxyflurane and sevoflurane metabolism. Intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity.
    Kharasch ED, Hankins DC, Thummel KE.
    Anesthesiology; 1995 Mar; 82(3):689-99. PubMed ID: 7879937
    [Abstract] [Full Text] [Related]

  • 3. Human liver microsomal enflurane defluorination catalyzed by cytochrome P-450 2E1.
    Thummel KE, Kharasch ED, Podoll T, Kunze K.
    Drug Metab Dispos; 1993 Mar; 21(2):350-7. PubMed ID: 8097708
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Biotransformation of sevoflurane.
    Kharasch ED.
    Anesth Analg; 1995 Dec; 81(6 Suppl):S27-38. PubMed ID: 7486145
    [Abstract] [Full Text] [Related]

  • 6. Lauric acid as a model substrate for the simultaneous determination of cytochrome P450 2E1 and 4A in hepatic microsomes.
    Clarke SE, Baldwin SJ, Bloomer JC, Ayrton AD, Sozio RS, Chenery RJ.
    Chem Res Toxicol; 1994 Dec; 7(6):836-42. PubMed ID: 7696540
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Stereoselective metabolism of enflurane by human liver cytochrome P450 2E1.
    Garton KJ, Yuen P, Meinwald J, Thummel KE, Kharasch ED.
    Drug Metab Dispos; 1995 Dec; 23(12):1426-30. PubMed ID: 8689955
    [Abstract] [Full Text] [Related]

  • 10. Clinical sevoflurane metabolism and disposition. II. The role of cytochrome P450 2E1 in fluoride and hexafluoroisopropanol formation.
    Kharasch ED, Armstrong AS, Gunn K, Artru A, Cox K, Karol MD.
    Anesthesiology; 1995 Jun; 82(6):1379-88. PubMed ID: 7793652
    [Abstract] [Full Text] [Related]

  • 11. Effect of phenytoin (DPH) treatment on methoxyflurane metabolism in rats.
    Caughey GH, Rice SA, Kosek JC, Mazze RI.
    J Pharmacol Exp Ther; 1979 Aug; 210(2):180-5. PubMed ID: 458627
    [Abstract] [Full Text] [Related]

  • 12. Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.
    Köster U, Speerschneider P, Kerssebaum R, Wittmann H, Dekant W.
    Drug Metab Dispos; 1994 Aug; 22(5):667-72. PubMed ID: 7835215
    [Abstract] [Full Text] [Related]

  • 13. Effect of streptozotocin-induced diabetes in the rat on the metabolism of fluorinated volatile anesthetics.
    Pantuck EJ, Pantuck CB, Conney AH.
    Anesthesiology; 1987 Jan; 66(1):24-8. PubMed ID: 3541691
    [Abstract] [Full Text] [Related]

  • 14. Clinical enflurane metabolism by cytochrome P450 2E1.
    Kharasch ED, Thummel KE, Mautz D, Bosse S.
    Clin Pharmacol Ther; 1994 Apr; 55(4):434-40. PubMed ID: 8162670
    [Abstract] [Full Text] [Related]

  • 15. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
    Spracklin DK, Thummel KE, Kharasch ED.
    Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607
    [Abstract] [Full Text] [Related]

  • 16. Ethanol-inducible cytochrome P450 in rabbits metabolizes enflurane.
    Hoffman J, Konopka K, Buckhorn C, Koop DR, Waskell L.
    Br J Anaesth; 1989 Jul; 63(1):103-8. PubMed ID: 2765333
    [Abstract] [Full Text] [Related]

  • 17. Enflurane, isoflurane, and methoxyflurane metabolism in rat hepatic microsomes from ethanol-treated animals.
    Van Dyke RA.
    Anesthesiology; 1983 Mar; 58(3):221-4. PubMed ID: 6829956
    [Abstract] [Full Text] [Related]

  • 18. Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro.
    Spracklin DK, Hankins DC, Fisher JM, Thummel KE, Kharasch ED.
    J Pharmacol Exp Ther; 1997 Apr; 281(1):400-11. PubMed ID: 9103523
    [Abstract] [Full Text] [Related]

  • 19. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
    Patten CJ, Smith TJ, Murphy SE, Wang MH, Lee J, Tynes RE, Koch P, Yang CS.
    Arch Biochem Biophys; 1996 Sep 01; 333(1):127-38. PubMed ID: 8806763
    [Abstract] [Full Text] [Related]

  • 20. Metabolism of synthane: comparison with in vivo and in vitro defluorination of other halogenated hydrocarbon anaesthetics.
    Mazze RI, Beppu WJ, Hitt BA.
    Br J Anaesth; 1979 Sep 01; 51(9):839-44. PubMed ID: 508489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.